Molecular and cellular mechanisms of antibody activity / / Falk Nimmerjahn, editor
| Molecular and cellular mechanisms of antibody activity / / Falk Nimmerjahn, editor |
| Edizione | [1st ed. 2013.] |
| Pubbl/distr/stampa | New York, : Springer, 2013 |
| Descrizione fisica | 1 online resource (300 p.) |
| Disciplina | 616.0798 |
| Altri autori (Persone) | NimmerjahnFalk |
| Soggetto topico |
Antigen-antibody reactions
Immunospecificity Binding sites (Biochemistry) |
| ISBN | 1-4614-7107-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | IgM and IgD in infection and inflammatory diseases -- Immunoglobulin A – molecular mechanisms of function and role in immune defense -- Crystal structures of human IgG Fc-fragments and their complexes with Fc Receptors -- The role of IgG in immune responses -- Molecular and cellular pathways involved in the anti-inflammatory activity of IgG -- Example of the Pathogenic Potential of Two Sets of Autoantibodies: Anti-RBC and IgG3 RF Cryoglobulins -- Cross-talk between antibodies, IgG Fc receptors and the complement system -- Regulation of immunological responses by the neonatal Fc receptor for IgG, FcRn -- Antibody mediated regulation of humoral immunity -- Engineered antibody derivatives in preclinical and clinical development. |
| Record Nr. | UNINA-9910437843403321 |
| New York, : Springer, 2013 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The natural anti-gal antibody as foe turned friend in medicine / / Uri Galili
| The natural anti-gal antibody as foe turned friend in medicine / / Uri Galili |
| Autore | Galili Uri |
| Pubbl/distr/stampa | London, England : , : Academic Press, , 2018 |
| Descrizione fisica | 1 online resource (301 pages) : illustrations (some color) |
| Disciplina | 612.11822 |
| Soggetto topico |
Antigen-antibody reactions
Antigens - Analysis |
| ISBN |
0-12-813363-5
0-12-813362-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Anti-gal in humans and its antigen the [alpha]-gal epitope -- Why do we produce anti-gal -- Anti-gal comprises most of anti-blood group b antibodies -- Anti-gal interaction with Trypansoma, Leishmania, and Plasmodium parasites -- Anti-gal b cells are tolerized by a [alpha]-gal epitopes in the absence of t cell help -- Anti-gal and other immune barriers in xenotransplantation -- Anti-gal IgE mediates allergies to red meat -- Anti-gal and autoimmunity -- Anti-gal-mediated amplification of viral vaccine efficacy -- Cancer immunotherapy by anti-gal-mediated in situ conversion of tumors into autologous vaccines -- Anti-gal as cancer cell destroying antibody and as antibiotics targeted by [alpha]-gal bifunctional molecules -- Acceleration of wound and burn healing by anti-gal/[alpha]-gal nanoparticles interaction -- Anti-gal and anti-non gal antibodies in regeneration of extracellular matrix bio-implants -- Post infarction regeneration of ischemic myocardium by intramyocardial injection of [alpha]-gal nanoparticles -- Regeneration of injured spinal cord and peripheral nerves by [alpha]-gal nanoparticles -- Inhalation of [alpha]-gal/sialic acid liposomes for decreasing influenza virus infection. |
| Record Nr. | UNINA-9910583071203321 |
Galili Uri
|
||
| London, England : , : Academic Press, , 2018 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||